Electrophoresis Reagents Market is Segmented By Product Type (Gels, Dyes), By Technique (Gel electrophoresis, Capillary electrophoresis), By End-User (Academic and research institutions, Pharmaceutical and biotechnology companies, Hospital laboratories, Other end users), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) â Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Electrophoresis Reagents Market size was worth US$ YY billion in 2020 and is estimated to reach US$ YY billion by 2029, growing at a CAGR of 4.36% % during the forecast period (2023-2030). Electrophoresis is a technique used to separate DNA, RNA and Protein-based on their size and charge. The techniques are used to determine the size and type of macromolecules from the sample. The techniques are based on applying electric charge at the ends of the assembly into which gel loaded with fluorescence dyes attached to the sample is placed. According to the charge of the sample, the macromolecules move from one end towards the other end, and after the process is completed, the gel is placed under a UV light source to see the bands formed by the movement of the macromolecules. It has a wide range of applications like identifying molecular markers in genotyping of the organism species, verifying gene sequences' amplification, checking quality and quantity of DNA, RNA and protein samples after extraction and separating DNA fragments in cloning. Owing to the increasing focus on biological therapies based on alteration DNA and RNA, the use of the electrophoresis technique is increasing rapidly, increasing demand for electrophoresis reagents over the forecast period.
Electrophoresis Reagents Market
|
Metrics |
Details |
|
Market CAGR |
4.36% |
|
Segments Covered |
By Product Type, By Technique, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
To Get a Free sample click here
Market Dynamics
Electrophoresis Reagents market growth is driven by the Growing adoption of electrophoresis techniques in biotechnology and pharmaceutical industry, increasing funding in the R&D activities related to genomics and proteomics, rising prevalence of chronic diseases, increasing collaborations between industry and academics, and technological developments.
The rising prevalence of chronic diseases, is expected to drive the global Electrophoresis Reagents market growth.
According to the World Health Organization (WHO), in 2020, the prevalence of chronic diseases increased by 57%. Additionally, as per the International Diabetes Federation (IDF) 2020, globally, around 463 million people with diabetes in 2020 and 88 million people in the Southeast Asian region. In India, there were around 77 million people with diabetes. The prevalence of diabetes in the population was 8.9%.
Furthermore, with the increasing cases of chronic diseases such as diabetes, prompt diagnosis and treatment are in need. This has given rise to electrophoresis used in clinical laboratories to quantify the lipoproteins using enzymatic staining of cholesterol and triglycerides to diagnose cardiovascular diseases and other chronic diseases, like diabetes.
Time-consuming operations and limited sample analysis are likely to hinder the growth of the market
Electrophoresis is mostly used techniques in molecular biochemistry, microbiology, biomedical research. It is a type of protein separation method which relies on protein sizes to segregate the mixture.
It is a highly effective analysis technique and the sole method for separating proteins for western blot RNA studies. It is also a time-consuming, expensive, and technical skilled procedure due to which is acting as a restricting factor of the market.
COVID-19 Impact Analysis
Globally, the COVID-19 outbreak was an incomparable public health emergency that affected almost every industry. The pandemic has had a positive impact on the market growth because the electrophoresis technique has been used to develop effective therapies, as it is used to separate DNA, RNA, or protein molecules based on their size in the development of effective therapies for COVID-19.
For instance, as per the National Clinical Trial (NCT) Registry, Elsan conducts a clinical trial to assess serum inflammation profiles by protein electrophoresis on patients hospitalized for infection due to the SARS-CoV-2 virus. Thus, increasing research and development activities in developing effective therapies are expected to increase the demand for electrophoresis reagents in the forecast period.
Segment Analysis
Based on the Product Type, Gels (Agarose gels, Polyacrylamide gels, and Starch gels), Dyes (Ethidium bromide (ETBR) dyes, Bromophenol blue, Sybr dyes, and Other dyes), Buffers (tris/acetate/EDTA, tris/borate/EDTA, and Other buffers), and Other products
The gels segment accounts for the largest share owing to the growing application of gels in protein analysis and DNA & RNA analysis. Agarose gel electrophoresis is a technique that can separate biomolecules like DNA, RNA, or proteins based on their charges. To separate DNA, under the current influence, the negatively charged DNA migrates towards the positive charge. DNA fragments separate in gel matrices based on their size and charge. Polyacrylamide gel electrophoresis (PAGE) is a technique used almost universally in life science laboratories. This technique aims to separate a mixed sample of proteins to identify and quantify single proteins from the mixture.
Based on the Technique, the global Electrophoresis Reagents Market is segmented into Gel electrophoresis and Capillary electrophoresis
The major driving factors of the gel electrophoresis segment include low operating and instrument cost, rising applications in the pharmaceutical and biotechnology industries, and the increasing burden of infectious diseases, cancer, and genetic disorders. There has been increasing use of gel-electrophoresis along with RT-PCR assays for the detection of SARS-CoV-2. For instance, a research article by Wischmann F-J et al., published in 2020, stated that using gel-electrophoresis in combination with conventional PCR for test analysis is a feasible approach to make SARS-CoV-2 diagnostics available in the whole world.
Gel electrophoresis is a separation technique and macromolecule analysis such as RNA, DNA, and proteins and their fragments based on their charge and size. It is used in clinical chemistry to separate proteins and molecular biology and biochemistry to separate a mixed population of RNA and DNA fragments by length, among others.
Based on End-Users, the global Electrophoresis Reagents Market is segmented into Academic and research institutions, Pharmaceutical and biotechnology companies, Hospital laboratories, and Other end users
The hospital laboratories segment held the largest share in the market. This is mainly owing to increasing number of patients suffering from conditions which are treated in hospitals equipped with advanced infrastructure and adequate facilities, strong financial capabilities of hospitals for purchasing high-priced equipments and the availability of trained professionals to operate electrophoresis process. Moreover, growing number of hospitals along with adequate reimbursement policies is also contributing to the growth of this segment.
Geographical Analysis
North America is expected to serve a significant market share in the global Electrophoresis Reagents due to the increasing number of proteomic and genomic research projects in Canada and the U.S., and strict regulatory requirements for the pharmaceutical sector in these countries are some of the major factors accounting for the high demand for electrophoresis technologies and correlated consumables in North American region. The presence of a highly developed healthcare system, the high degree of acceptance by medical practitioners of novel chemotherapy methods, the total availability of advanced technological tools, FDA approval of new drugs, and a vast number of organizations engaged in R&D activities related to cancer vaccines. For instance, in May 2017, Thermo Fisher Scientific announced new capillary electrophoresis (CE) system designed to offer a low-throughput and cartridge-based system. It is designed for usage in research and diagnostic systems.
The Asia-Pacific region is also expected to be the fastest-growing market. In the emerging economies of China, Japan, and India, there has been an increasing number of research activities going on in academic and research institutions and pharmaceutical and biotechnology companies, and increasing adoption of advanced technology and rising health awareness are some of the key factors contributing to the market growth.
Japanese scientists have developed a new method to identify single virus particles based on changes in electrical current through the electrophoresis process. For instance, in 2020, scientists from Osaka University developed a new method for fast and accurate screening tests in the diagnosis of diseases like COVID-19 and influenza. Thus, growing research and development activities in developing new diagnostic approaches based on electrophoresis techniques are expected to drive the demand for reagents.
The high growth is also majorly attributed to the rapidly improving healthcare infrastructure and low labor costs in emerging countries. According to the World Health Organization (WHO) 2018 report, chronic diseases such as cardiovascular, chronic respiratory diseases, diabetes, and cancer were top killers in the Southeast Asian region, claiming an estimated 8.5 million lives each year.
Competitive Landscape
The global Electrophoresis Reagents market is highly competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Agilent Technologies Inc., BioAtlas, Bio-Rad Laboratories Inc., Cytiva, Lonza Group AG, Merck KGaA, Qiagen NV, Sigma-Aldrich Corporation, Takara Bio Inc., and Thermo Fisher Scientific. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the electrophoresis reagents market globally. For instance, In September 2020, Hitachi High-Tech Corporation launched the Hitachi DS3000 compact capillary electrophoresis (CE) sequencer. The Hitachi DS3000 was developed in collaboration between Hitachi High-Tech Corporation and Promega Corporation.
Agilent Technologies Inc
Company Overview: Agilent is a leader in life sciences, diagnostics and applied chemical markets established on Nov. 18, 1999. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. With the team of 16,300 employees spread across the world. The majority of research is located in the United States in Santa Clara, California, with additional locations in Europe and Asia.
Product Portfolio: The Company's products include Environmental and Forensics, Food, Pharmaceutical, Diagnostics, Research, Chemical and Energy.
Product: Capillary Electrophoresis and CE/MS Systems for Superior Analysis.
Key Developments: Agilent Technologies Inc. (U.S.) launched updated Sure Print gene expression microarrays for messenger RNA profiling applications for human, mouse, and rat models.